Avinger, Inc. (NASDAQ:AVGR) Short Interest Update

Avinger, Inc. (NASDAQ:AVGR) was the recipient of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 234,700 shares, a growth of 301.9% from the December 31st total of 58,400 shares. Based on an average daily volume of 1,990,000 shares, the short-interest ratio is currently 0.1 days. Approximately 8.5% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Avinger in a research note on Tuesday, January 21st. They set a “hold” rating on the stock.

Avinger Price Performance

Shares of AVGR traded down $0.02 during midday trading on Tuesday, reaching $0.55. The stock had a trading volume of 73,938 shares, compared to its average volume of 916,690. The company’s fifty day simple moving average is $0.75 and its two-hundred day simple moving average is $0.98. The company has a market cap of $1.82 million, a price-to-earnings ratio of -0.05 and a beta of 1.15. Avinger has a 1-year low of $0.39 and a 1-year high of $5.45.

Avinger (NASDAQ:AVGR) last posted its earnings results on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, topping the consensus estimate of ($2.03) by $0.21. The firm had revenue of $1.65 million during the quarter, compared to analysts’ expectations of $1.60 million. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. During the same quarter in the previous year, the business earned ($2.92) earnings per share. On average, sell-side analysts forecast that Avinger will post -4.69 earnings per share for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.